COVID-19: use intersectional analyses to close gaps in outcomes and vaccination
Nature
.
2021 Mar;591(7849):202.
doi: 10.1038/d41586-021-00577-z.
Authors
Janna R Shapiro
,
Sabra L Klein
,
Rosemary Morgan
PMID:
33658677
DOI:
10.1038/d41586-021-00577-z
No abstract available
Keywords:
Immunology; Medical research; Public health.
Publication types
Letter
Comment
MeSH terms
Anaphylaxis*
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
United States
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
U54 AG062333/AG/NIA NIH HHS/United States